The AlgZR Two-Component System Recalibrates the RsmAYZ Posttranscriptional Regulatory System To Inhibit Expression of the Pseudomonas aeruginosa Type III Secretion System by Intile, P. J. et al.
The AlgZR Two-Component System Recalibrates the RsmAYZ
Posttranscriptional Regulatory System To Inhibit Expression of the
Pseudomonas aeruginosa Type III Secretion System
Peter J. Intile,a Manisha R. Diaz,a Mark L. Urbanowski,a Matthew C. Wolfgang,b Timothy L. Yahra
‹Department of Microbiology, University of Iowa, Iowa City, Iowa, USAa; Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North
Carolina, USAb
Pseudomonas aeruginosa causes chronic airway infections in cystic fibrosis (CF) patients. A classic feature of CF airway isolates
is the mucoid phenotype. Mucoidy arises through mutation of the mucA anti-sigma factor and subsequent activation of the AlgU
regulon. Inactivation of mucA also results in reduced expression of the Vfr transcription factor. Vfr regulates several important
virulence factors, including a type III secretion system (T3SS). In the present study, we report that ExsA expression, the master
regulator of T3SS gene expression, is further reduced in mucA mutants through a Vfr-independent mechanism involving the
RsmAYZ regulatory system. RsmA is an RNA binding protein required for T3SS gene expression. Genetic experiments suggest
that the AlgZR two-component system, part of the AlgU regulon, inhibits ExsA expression by increasing the expression of RsmY
and RsmZ, two small noncoding RNAs that sequester RsmA from target mRNAs. Epistasis analyses revealed that increasing the
concentration of free RsmA, through either rsmYZ deletion or increased RsmA expression, partially restored T3SS gene expres-
sion in the mucA mutant. Furthermore, increasing RsmA availability in combination with Vfr complementation fully restored
T3SS expression. Recalibration of the RsmAYZ system by AlgZR, however, did not alter the expression of other selected RsmA-
dependent targets. We account for this observation by showing that ExsA expression is more sensitive to changes in free RsmA
than other members of the RsmA regulon. Together, these data indicate that recalibration of the RsmAYZ system partially ac-
counts for reduced T3SS gene expression in mucA mutants.
Pseudomonas aeruginosa is a Gram-negative bacterium with theability to cause both acute and chronic infections (1, 2). Im-
munocompromised individuals often develop acute P. aeruginosa
infections that can become systemic, with lethal sepsis as a com-
mon outcome (3). Isolates from acute P. aeruginosa infections are
generally characterized by the presence of a functional type III
secretion system (T3SS) (4, 5). The T3SS injects multiple effectors
directly into the host cell cytoplasm, where they function to de-
regulate signal transduction mechanisms and promote phagocytic
avoidance and host cell killing (6–8). In contrast to acute infec-
tions, the airways of most adults with the genetic disorder cystic
fibrosis (CF) are chronically colonized with P. aeruginosa. CF pa-
tients are initially colonized with environmental strains of P.
aeruginosa that subsequently undergo diversification via mutation
and selection by the CF airway environment to generate a popu-
lation of cells adapted for persistence, host immune defense, an-
tibiotic resistance, and biofilm formation (9–11).
A common phenotype observed in CF isolates is the loss of
T3SS gene expression (12, 13). One mechanism that accounts for
reduced T3SS expression involves the MucA/AlgU signal trans-
duction system (see Fig. 8 for a model). MucA is a membrane-
bound anti-sigma factor that sequesters the alternative sigma
factor AlgU to control expression of 300 genes (14–16). Inacti-
vating mutations in mucA are common in CF isolates and result in
high-level expression of the AlgU regulon (14, 17, 18). The AlgU
regulon includes membrane stress responses and the alginate bio-
synthetic gene cluster, overproduction of which results in the mu-
coid phenotype (14, 17, 19). The presence of mucoid P. aeruginosa
isolates in the CF airways correlates with a decline in lung func-
tion, advanced disease, and increased morbidity (20, 21). Multiple
regulators, including the AlgZR two-component system, control
alginate biosynthesis (22–24). Elevated AlgU activity in the mucA
mutant results in increased AlgZR activity (22). Previous studies
found that mucA mutation or overexpression of AlgZR from a
plasmid results in a significant decrease in T3SS gene expression
(25, 26). One potential explanation for decreased T3SS expression
in mucA mutants is that the activity of the cyclic AMP (cAMP)-Vfr
signaling pathway is also decreased (26). Vfr promotes the expres-
sion of multiple acute virulence factors, including the T3SS (27).
The mechanism by which Vfr stimulates T3SS gene expression is
unknown.
Similar to Vfr, RsmA also has a positive effect on T3SS gene
expression (28). RsmA is a member of the CsrA family of RNA
binding proteins and functions as a global posttranscriptional reg-
ulator of gene expression. The RsmAYZ system inversely controls
numerous phenotypes associated with acute and chronic infec-
tions (28–30). CsrA/RsmA proteins typically inhibit gene expres-
sion by binding to conserved 5=-ANGGAN-3= motifs presented
within stem-loop secondary structures of target mRNAs (31–35).
CsrA/RsmA binding sites are often located adjacent to or overlap
the Shine-Dalgarno sequences of target genes (31, 35, 36). CsrA/
RsmA proteins can also stimulate gene expression by altering
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mRNA stability, mRNA secondary structure, and/or ribosomal re-
cruitment (34, 37). Although RsmA has a positive effect on T3SS gene
expression, the RsmA-controlled target has not been identified.
The intracellular concentration of free RsmA dictates the out-
put of the RsmA regulon, including T3SS expression. T3SS expres-
sion is reduced when the concentration of free RsmA is low (28,
30). The concentration of free RsmA is regulated by two small
noncoding RNAs, RsmY and RsmZ (38, 39). RsmY and RsmZ
each possess 4 to 6 binding sites for homodimeric RsmA and act to
titrate free RsmA away from mRNA targets (40, 41). Changes in
RsmYZ expression, therefore, control the output of the RsmA
regulon (39, 42). The GacAS two-component system regulates
RsmYZ expression (42). The GacA response regulator directly
binds to and activates the PrsmY and PrsmZ promoters when phos-
phorylated by the GacS sensor kinase (38, 41–44). Two orphan
sensor kinases, RetS and LadS, reciprocally control RsmYZ ex-
pression through GacAS (45–47). RetS inhibits RsmYZ expression
by forming a heterodimer with GacS which prevents phosphory-
lation of GacA (48). Conversely, LadS activates RsmYZ expression
through GacAS, but a mechanism of action has not yet been de-
scribed (47).
In the present study, we identified a second AlgZR-dependent
mechanism that inhibits T3SS gene expression. This mechanism
works concurrently with and independently from the docu-
mented Vfr defect mediated by AlgZR and inhibits ExsA expres-
sion at a posttranscriptional level, reducing the availability of
RsmA. In conjunction with restoration of Vfr expression, in-
creased free RsmA allowed for full restoration of T3SS gene ex-
pression in the mucA mutant. Finally, we propose that ExsA ex-
pression responds to smaller alterations in free RsmA than other
RsmA-dependent targets.
MATERIALS AND METHODS
Bacterial strains, culture conditions, and sample preparation. The bac-
terial strains used in this study are listed in Table S1 in the supplemental
material. Escherichia coli DH5 was used for all cloning and maintained
on LB-Miller agar plates with gentamicin (15 g/ml), tetracycline (15
g/ml), or ampicillin (100 g/ml) as necessary. P. aeruginosa strains were
cultured on Vogel-Bonner minimal medium (49) agar plates and supple-
mented with gentamicin (100 g/ml) as required. For transcriptional and
translational reporter assays, P. aeruginosa strains were cultured in Tryp-
ticase soy broth supplemented with 100 mM monosodium glutamate, 1%
glycerol, and 1 mM EGTA to an absorbance at 600 nm (A600) of 1.0. In
some reporter assays, 0.4% arabinose as added to induce expression of
plasmid-borne genes under the transcriptional control of an arabinose-
inducible promoter. -Galactosidase activity was measured using the sub-
strate ortho-nitrophenyl-galactopyranoside (ONPG) (Miller units) or
chlorophenol red–-D-galactopyranoside (CPRG) (CPRG units) (50).
The reported values for all reporter assays denote the average from at least
three independent experiments divided by the activity of a control strain,
and error bars represent the standard deviation.
Whole-cell lysate samples were prepared by pelleting 1.25 ml (A600 
1.0) of cells, suspending the pellet in 0.25 ml SDS-PAGE sample buffer,
sonicating for 10 s, and heating for 5 min at 95°C. Samples were analyzed
by SDS-PAGE followed by immunoblotting using the indicated antibod-
ies and processed using enhanced chemiluminescent fluorescence detec-
tion reagents (Thermo Scientific, Rockford, IL).
Mutant and expression vector construction. The transcriptional and
translational reporters, complementation plasmids, and allelic exchange
vectors used in this study are listed in Table S2 in the supplemental ma-
terial. The details of the plasmid construction are provided in Table S3,
and the primers are listed in Table S4. All PCR products were amplified
from PA103 genomic DNA and verified by DNA sequencing. Allelic
exchange vectors were introduced into the desired strains as previously
described (51). Transcriptional and translational reporter fusions
were introduced into the CTX phage attachment site of the desired
strain as previously described (52). To construct p3UY51 (pUY68-
PlacUV5-exsCEBA=-=lacZ), the PlacUV5 promoter was generated via PCR us-
ing primers 33914045-44895670 and inserted into the HindIII-NcoI sites
of pUY68. Subsequent translational fusions (p3UY51-PlacUV5-exsCEB=-=lacZ,
p3UY51-PlacUV5-exsCE=-=lacZ, p3UY51-PlacUV5-exsC=-=lacZ, and p3UY51-
PlacUV5-exsD=-=lacZ) were constructed by cloning PCR products into the
EcoRI-BamHI sites of p3UY51. The mini-CTX1-PlacUV5-exsCEBA=-=lacZ re-
porter was generated by cloning the PlacUV5-exsCEBA fragment from
p3UY51 into the EcoRI-BamHI sites of mini-CTX1. p3UY71
(pEXG2vfr) was constructed by PCR amplifying the vfr deletion allele
from PA103 vfr using primers 7299293-7299296 and cloning into the
HindIII-EcoRI sites of pEXG2. The pAlgR and pMucA expression vectors
were constructed by cloning the respective genes into the XbaI-SacI or
EcoRI-XbaI sites of pJN105, respectively. The p2UY137 (pVfr) expression
vector was constructed by cloning vfr into the NdeI-SacI sites of P35B.
pUY68-PPA4492=-=lacZ was constructed by cloning the PPA4492 promoter
region into the EcoRI-BamHI sites of pUY68. pEXG2gacA was con-
structed by PCR amplifying upstream (78241012-78241013) and down-
stream (78241010-78241011) flanking regions of gacA and cloning into
the KpnI-XbaI sites of pEXG2. The mini-CTX-PrsmY-lacZ, PrsmZ-lacZ,
PgacA-lacZ, PgacS-lacZ, PretS-lacZ, and PladS-lacZ reporters were constructed by
cloning the desired promoter fragment into the EcoRI-BamHI sites of
mini-CTX1. p3UY36 (pEXG2-P35B) was constructed in three steps. First,
the rpoC transcriptional terminator from pOM90 was amplified using
primers 45403337-45420277 and cloned into the SphI restriction site of
p2UY36, creating vector p2UY104. Second, the terminator-P35B pro-
moter fragment was excised from p2UY104 and inserted into the HindIII-
XhoI sites of pEXG2. Finally, the exsCEBA region from p2UY104 was
cloned into the SphI-SacI sites of the above-described vector, creating
p3UY36.
Statistical analyses. Two-tailed unpaired t tests were used for data
analyses when comparing two groups. One-way analysis of variance
(ANOVA) and Tukey’s posttest were used to determine statistical signif-
icance when comparing three or more groups. Statistical analyses were
performed using Prism 5.0c (GraphPad Software, Inc., La Jolla, CA).
RESULTS
Reduced T3SS gene expression in mucA mutants occurs
through Vfr-dependent and -independent mechanisms. Previ-
ous studies found that Vfr is required for maximal T3SS gene
expression (27) and that Vfr expression is reduced in a mucA
mutant (26). Vfr insufficiency, therefore, is the simplest model to
account for reduced T3SS gene expression in a mucA mutant and
is consistent with the finding that overexpression of Vfr in trans
restores T3SS gene expression in a mucA mutant (26). If reduced
T3SS gene expression in the mucA mutant were solely attributable
to Vfr insufficiency then T3SS gene expression should remain un-
changed in a mucA vfr double mutant. Using the previously de-
scribed PexsD-lacZ transcriptional reporter as a marker for T3SS
gene expression (53), however, we found that reporter activity and
ExsA expression were significantly reduced in the mucA vfr double
mutant compared to either of the single mutants alone (Fig. 1A).
To further examine the role of Vfr, we exploited the fact that
plasmid-expressed AlgR phenocopies a mucA mutant with regard
to T3SS gene expression (25, 26) (Fig. 1B). We again predicted
that if Vfr insufficiency were the sole explanation for decreased
T3SS expression, then AlgR expressed in a vfr single mutant
should result in no further decrease in T3SS expression. Expres-
sion of AlgR in the vfr mutant, however, resulted in a further decrease
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in PexsD-lacZ reporter activity relative to that of the vector control
(pJN105). These combined data indicate that Vfr insufficiency alone
cannot account for reduced T3SS gene expression in the mucA mu-
tant and suggest that an additional inhibitory mechanism exists.
mucA and rsmA mutants have a posttranscriptional defect in
ExsA expression. The ExsECD regulatory cascade serves as the
primary means to activate T3SS gene expression in response to
calcium limitation or host cell contact and controls ExsA-depen-
dent transcription (54). Transcription of the exsCEBA operon is
positively autoregulated by ExsA through the PexsC promoter (55).
We hypothesized that transcription of the exsCEBA operon
and/or expression of an exsCEBA gene product(s) is disrupted in
the mucA mutant. To differentiate transcriptional from posttran-
scriptional effects on expression of the exsCEBA operon, we re-
placed the ExsA-dependent PexsC promoter with a constitutive de-
rivative of the PlacUV5 promoter (P35B), resulting in strain UY339
(Fig. 2A). PA103 and UY339 were then cultured under noninduc-
ing (high Ca2, without EGTA) and inducing (low Ca2, with
EGTA) conditions for T3SS gene expression and assayed for
PexsD-lacZ reporter activity and ExsC and ExsA expression. Consis-
FIG 1 Both Vfr-dependent and -independent mechanisms account for re-
duced T3SS gene expression in mucA mutants. (A) The indicated strains car-
rying the ExsA-dependent PexsD-lacZ transcriptional reporter were cultured un-
der low-Ca2 conditions (1 mM EGTA) until the A600 reached 1.0. Cells were
then harvested, assayed for -galactosidase activity, and immunoblotted for
ExsA and Vfr. The activity of wt PA103 was 2,291 Miller units. All of the values
reported in this paper were normalized to those for wt PA103 or wt PA103
carrying the vector control (pJN105) and represent the average from at least
three experiments. **, P 	 0.001; ***, P 	 0.0001. (B) PA103 and a vfr mutant
were transformed with a vector control (pJN105) or an arabinose-inducible
AlgR expression plasmid (pAlgR). The resulting strains were cultured in the
presence of 1 mM EGTA and 0.4% arabinose and assayed for PexsD-lacZ reporter
activity. The activity of wild-type PA103 carrying the vector control was 2,319
Miller units. ***, P 	 0.0001. FIG 2 Both mucA and rsmA mutants have a posttranscriptional defect in T3SS
gene expression. (A) Diagram of the exsCEBA operon and transcriptional con-
trol by the ExsA-dependent PexsC promoter. In strain UY339, PexsC has been
replaced with P35B, a constitutive derivative of the lacUV5 promoter. (B)
PA103 and strain UY339 were cultured under noninducing (high Ca2, with-
out EGTA) or inducing (low Ca2, with EGTA) conditions for T3SS gene
expression and assayed for PexsD-lacZ reporter activity. The activity of wild-type
PA103 cultured under inducing conditions was 2,150 Miller units. For both
panels A and B, whole-cell lysates were immunoblotted for ExsC and ExsA. **,
P 	 0.001. (C) The indicated strains carrying either a vector control (pJN105)
or MucA, Vfr, or RsmA expression vector (pMucA, pVfr, and pRsmA) were
cultured under inducing conditions for T3SS gene expression and assayed for
PexsD-lacZ reporter activity. Values reported in panel C were normalized to
those for the wt UY339 strain carrying the vector control (777 Miller units).
**, P 	 0.001.
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tent with a previous report, PexsD-lacZ reporter activity and ExsC
and ExsA expression were induced when the wild-type (wt) strain
(PA103) was cultured under low-Ca2 conditions (56) (Fig. 2B).
In strain UY339, PexsD-lacZ reporter activity was only modestly in-
duced in response to low-Ca2 conditions. Importantly, steady-
state levels of ExsC and ExsA expression were similar under both
high- and low-Ca2 conditions, indicating that exsCEBA tran-
scription is constitutive in strain UY339.
Having verified that exsCEBA expression is constitutive in
strain UY339, we introduced in-frame mucA and vfr deletions into
the UY339 background and assayed the resulting strains for ExsA-
dependent PexsD-lacZ transcriptional reporter activity. The UY339
mucA mutant demonstrated a significant reduction in reporter
activity that was partially complemented by MucA expressed from
a plasmid (Fig. 2C). Although ExsA expression levels were signif-
icantly reduced in the UY339 mucA mutant, ExsC expression lev-
els were similar in strain UY339 and the UY339 mucA mutant.
Since exsC and exsA are encoded on the same polycistronic mRNA
(55) (Fig. 2A), this finding raised the possibility that the mucA
mutant has a posttranscriptional defect in ExsA expression.
In contrast to our findings for the UY339 mucA mutant, the
UY339 vfr mutant had PexsD-lacZ activity similar to that of the pa-
rental UY339 strain (Fig. 2C). These data suggest that decreased
PexsD-lacZ activity in the UY339 mucA mutant does not result from
the loss of Vfr expression and support our hypothesis that AlgZR
inhibits T3SS gene expression through a second, Vfr-indepen-
dent, mechanism.
Previous studies found that RsmA has a positive effect on T3SS
gene expression, but the mechanism has not been determined
(45). Given the established role of RsmA as a posttranscriptional
regulator of gene expression, we hypothesized that the mucA de-
fect in ExsA expression might be linked to RsmA function. As an
initial test of this hypothesis, we introduced an rsmA mutation
into strain UY339 and measured PexsD-lacZ reporter activity and
ExsC and ExsA protein levels. Interestingly, the phenotype of
UY339 rsmA was similar to that of the UY339 mucA mutant in that
PexsD-lacZ reporter activity and ExsA expression were reduced while
ExsC levels remained unchanged (Fig. 2C). PexsD-lacZ reporter ac-
tivity and ExsA expression were fully restored in the rsmA mutant
by the RsmA complementation plasmid.
To further examine the posttranscriptional defect in ExsA
expression and determine whether other components of the
ExsCED regulatory cascade are also subject to posttranscrip-
tional control, we integrated PlacUV5-exsC=-=lacZ, PlacUV5-exsCE=-=lacZ,
PlacUV5-exsCEB=-=lacZ, PlacUV5-exsCEBA=-=lacZ, and PlacUV5-exsD=-=lacZ
translational reporters into the CTX phage attachment sites of the
mucA and rsmA mutants (see Fig. S1 in the supplemental mate-
rial). Each reporter was transcribed from the constitutive PlacUV5
promoter to avoid detection of regulatory events occurring at
the transcriptional level. The only reporter in the exsCEBA
operon to demonstrate a significant change in activity was the
PlacUV5-exsCEBA=-=lacZ translational fusion, with 2-fold-decreased
activity in both the mucA and rsmA mutants (Fig. 3A). To verify
that the decreased activity of the PlacUV5-exsCEBA=-=lacZ reporter was
due to a posttranscriptional defect and not reduced activity of a
cryptic, unknown promoter within the exsCEBA operon, we con-
structed a transcriptional fusion (PlacUV5-exsCEBA-lacZ) with the
same sequence used to construct the translational fusion.
PlacUV5-exsCEBA-lacZ transcriptional reporter activity was similar in
wt PA103 and the mucA and rsmA mutants, further confirming
that the decreased activity of the PlacUV5-exsCEBA=-=lacZ translational
fusion resulted from a posttranscriptional defect (see Fig. S2 in the
supplemental material).
Reduced T3SS gene expression in mucA mutants is mediated
through the AlgZR two-component regulatory system (25, 26). To
determine whether this was also true for ExsA expression, the
PlacUV5-exsCEBA=-=lacZ translational reporter was introduced into the
mucA algZR mutant. As predicted, deletion of algZR in the mucA
mutant background restored PlacUV5-exsCEBA=-=lacZ activity to wt
levels (Fig. 3B). We also found that expression of AlgR in the wt
FIG 3 The posttranscriptional defect in mucA and rsmA mutants is specific to
ExsA. (A and B) The indicated strains carrying exsC=-=lacZ (371 CPRG units),
exsCE=-=lacZ (1,379 CPRG units for PA103), exsCEB=-=lacZ (292 CPRG units
for PA103), exsCEBA=-=lacZ (33 CPRG units for PA103), or exsD=-=lacZ (256
CPRG units for PA103) translational fusions, driven from the constitutive
PlacUV5 promoter, were cultured under inducing conditions for T3SS gene
expression and assayed for reporter activity. ***, P 	 0.0001. (C) PA103 car-
rying the exsCEBA=-=lacZ translational reporter was transformed with a vector
control (pJN105, 34 CPRG units) or an AlgR expression vector. The resulting
strains were cultured under inducing conditions for T3SS in the presence of
0.4% arabinose and assayed for exsCEBA=-=lacZ reporter activity.
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background reduced PlacUV5-exsCEBA=-=lacZ reporter activity 4-fold
compared to that of a vector control strain (Fig. 3C). Together,
these data indicate that rsmA and mucA mutants have a similar
posttranscriptional defect in ExsA expression and that the defect
in the mucA mutant is AlgZR dependent.
Increasing the level of free RsmA partially restores T3SS gene
expression in a mucA mutant. The finding that mucA and rsmA
mutants both possess a posttranscriptional defect specific to ExsA
suggested that the phenotypes are linked to one another. We hy-
pothesized that the concentration of free RsmA is reduced in the
mucA mutant. To test this idea, we introduced an arabinose-in-
ducible RsmA expression vector (pRsmA) into the mucA mutant
and found that PexsD-lacZ reporter activity increased 3- to 4-fold
(Fig. 4A). Compared to the case in the parental strain carrying the
vector control, however, plasmid-expressed RsmA was unable to
fully restore T3SS gene expression in the mucA mutant.
A previous study reported that expression of the RsmY and
RsmZ regulatory RNAs is significantly reduced in an rsmA mutant
(Fig. 4B) (57). We observed the same using PrsmY-lacZ and PrsmZ-lacZ
transcriptional reporters and also saw that plasmid-expressed
RsmA results in a significant increase in PrsmY-lacZ and PrsmZ-lacZ
reporter activities (Fig. 4B) relative to that of the vector control.
Based on those findings, we hypothesized that plasmid-expressed
RsmA results in only a modest increase in the level of free RsmA,
owing to negative feedback by increased expression of the RsmA-
sequestering RsmY and RsmZ RNAs. Such an outcome could ac-
count for the limited restoration of PexsD-lacZ reporter activity by
pRsmA in the mucA mutant (Fig. 4A). To test this possibility, we
constructed a mucA rsmYZ triple mutant and found that PexsD-lacZ
reporter activity was increased 2-fold relative to that in the mucA
mutant (Fig. 4A). These combined data indicate that increased
RsmA activity, whether it be through increased RsmA expression
or elimination of the RsmA-antagonizing RsmYZ small RNAs
(sRNAs), partially restores T3SS expression in the mucA mutant.
Restoration of Vfr expression in conjunction with increased
free RsmA restores T3SS expression in a mucA mutant. The ob-
servations that Vfr expression is reduced in a mucA mutant (26)
and that increased free RsmA partially restores T3SS gene expres-
sion in a mucA mutant (Fig. 4A) prompted us to test whether
plasmid-expressed RsmA would also restore Vfr expression in the
mucA background. To examine this possibility, we used the pre-
viously described Vfr-dependent PlacP1-lacZ transcriptional re-
porter integrated at the chromosomal CTX phage attachment site
(52). Whereas pMucA provided in trans increased PlacP1-lacZ re-
porter activity to wt levels in the mucA mutant, pRsmA had no
FIG 4 Combined restoration of RsmA and Vfr activities restores T3SS gene
expression in the mucA mutant. (A) The indicated strains transformed with
either a vector control (pJN105) or Vfr and RsmA expression vectors were
cultured under T3SS-inducing conditions and assayed for PexsD-lacZ reporter
activity. The activity of PA103 carrying the vector control was 1,548 Miller
units. (B) PA103 and an rsmA mutant carrying the PrsmY-lacZ or PrsmZ-lacZ
transcriptional reporter were transformed with a vector control (pJN105) or
an RsmA expression vector. The resulting strains were cultured under T3SS-
inducing conditions until the A600 reached 1.0 and were assayed for reporter
activity. The activities of the PrsmY-lacZ and PrsmZ-lacZ reporters in PA103 carry-
ing the vector control were 3,031 and 491 Miller units, respectively. (C) The
indicated strains transformed with either a vector control (pJN105) or MucA
and RsmA expression vectors (pMucA or pRsmA) were cultured under T3SS-
inducing conditions and assayed for expression of the Vfr-dependent
PlacP1-lacZ reporter. The activity of PA103 carrying the vector control was 792
Miller units. (D) The indicated strains were transformed with either a vector
control (pJN105) or an AlgR expression vector and were assayed for PexsD-lacZ
reporter activity under T3SS-inducing conditions and in the presence of 0.4%
arabinose. The activities of PA103 and the vfr, rsmYZ, and rsmYZ vfr mutants
carrying the vector control were 1,875, 266, 6,652, and 1,356 Miller units,
respectively.
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effect on reporter activity (Fig. 4C). The latter finding suggests
that the defects in ExsA and Vfr expression observed in the mucA
mutant occur through distinct mechanisms and that Vfr expres-
sion is reduced in the mucA mutant independently of RsmA.
Our data to this point suggested that the availabilities of Vfr
and free RsmA are both limiting in the mucA mutant and that
plasmid-expressed RsmA is unable to correct the Vfr expression
defect (Fig. 4C). We reasoned, therefore, that simultaneous resto-
ration of both Vfr and RsmA activity in the mucA mutant would
restore T3SS gene expression to wt levels. Increasing Vfr expres-
sion in the mucA mutant or elevating the level of free RsmA
(through rsmYZ deletion) stimulated PexsD-lacZ reporter activity
5-fold or 10-fold, respectively, relative to the vector controls
(Fig. 4A). Combining both activities by expressing Vfr in the
mucA rsmYZ mutant restored PexsD-lacZ reporter activity to wt lev-
els (Fig. 4A). We conclude, therefore, that the loss of T3SS gene
expression in the mucA mutant results from the combined loss of
Vfr and RsmA activity.
Based upon the above findings, our working model is that AlgR
reduces both Vfr expression and free RsmA levels to inhibit T3SS
expression in a mucA mutant. One prediction of that model is that
plasmid-expressed AlgR should no longer inhibit T3SS expression
in an rsmYZ vfr triple mutant. Relative to the vector control, the
pAlgR expression plasmid resulted in strong inhibition of
PexsD-lacZ reporter activity in the vfr and rsmYZ mutants (Fig. 4D).
In contrast, inhibition by pAlgR was significantly attenuated in the
rsmYZ vfr triple mutant (Fig. 4D).
Expression of RsmA, RsmY, and RsmZ is increased in a mucA
mutant. The reduction in the concentration of free RsmA in the
mucA mutant could result from decreased RsmA expression
and/or increased RsmYZ expression. To examine this, transcrip-
tional reporters derived from the rsmA, rsmY, and rsmZ promoter
regions (PrsmA-lacZ, PrsmY-lacZ, and PrsmZ-lacZ) were introduced into
wt PA103 and the mucA, algZR, and mucA algZR deletion strains.
To our surprise, the activity of all three reporters was elevated
2-fold in the mucA mutant compared to wt PA103 (Fig. 5A).
The 2-fold increase in PrsmA-lacZ, PrsmY-lacZ, and PrsmZ-lacZ reporter
activities was suppressed in the mucA algZR mutant, and this cor-
relates with the finding that reduced T3SS gene expression in the
mucA mutant also requires AlgR. This conclusion is further sup-
ported by the finding that expression of AlgR in wt PA103 in-
creased the activity of the PrsmA-lacZ, PrsmY-lacZ, and PrsmZ-lacZ re-
porters 2- to 3-fold relative to that of the vector control (Fig. 5B).
These data indicate that transcription of rsmA, rsmY, and rsmZ is
increased in response to elevated AlgR activity.
The GacAS two-component system (42) and RsmA (Fig. 4B)
are both required for RsmYZ expression. To determine whether
the AlgR-dependent increase in RsmAYZ expression requires
GacA and RsmA, we measured PrsmA-lacZ, PrsmY-lacZ, and PrsmZ-lacZ
reporter activities in gacA, mucA gacA, rsmA, and mucA rsmA mu-
tants. PrsmY-lacZ and PrsmZ-lacZ reporter activities were significantly
decreased in the gacA and rsmA mutants and in the mucA gacA and
mucA rsmA mutants (Fig. 5C). Additionally, expression of pAlgR
in the gacA and rsmA mutants did not result in increased PrsmY-lacZ
FIG 5 PrsmA-lacZ, PrsmY-lacZ, and PrsmZ-lacZ transcriptional reporter activities are elevated in the mucA mutant. (A to C) The indicated strains carrying either a
PrsmA-lacZ, PrsmY-lacZ, or PrsmZ-lacZ transcriptional reporter were cultured under inducing conditions for T3SS gene expression until the A600 reached 1.0 and were
assayed for reporter activity. (A) The activities of the PrsmA-lacZ, PrsmY-lacZ, and PrsmZ-lacZ reporters in PA103 were 45, 828, and 104 Miller units, respectively. (B)
The activities of the PrsmA-lacZ, PrsmY-lacZ, and PrsmZ-lacZ reporters in PA103 carrying the vector control were 50, 3,370, and 464 Miller units, respectively. (C) The
activities of the PrsmA-lacZ, PrsmY-lacZ, and PrsmZ-lacZ reporters in PA103 were 48, 670, and 151 Miller units, respectively. (D) The indicated strains carrying either
a vector control (pJN105) or an AlgR expression vector were assayed for PrsmA-lacZ, PrsmY-lacZ, or PrsmZ-lacZ transcriptional reporter activities under T3SS-inducing
conditions and in the presence of 0.4% arabinose. The activities of the PrsmA-lacZ, PrsmY-lacZ, and PrsmZ-lacZ reporters in PA103 carrying the vector control were 53,
3,277, and 602 Miller units, respectively. *, P 	 0.05; ***, P 	 0.0001.
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and PrsmZ-lacZ reporter activity (Fig. 5D), indicating that rsmA and
gacA are epistatic to the mucA effect on PrsmY-lacZ and PrsmZ-lacZ
expression. PrsmA-lacZ activity, however, showed a much different
pattern and was unaffected by deletion of either rsmA or gacA in
the context of a mucA mutant (Fig. 5C). In addition, the pAlgR-
dependent increase in PrsmA-lacZ activity occurred independently
of rsmA and gacA (Fig. 5D). Together, these data demonstrate that
GacA and RsmA are required for increased RsmYZ expression in
the mucA mutant but not for increased RsmA expression.
We hypothesized that increased RsmYZ expression in the
mucA mutant may result from altered gacA, gacS, retS, and/or ladS
expression. RetS and LadS are hybrid sensor kinase/response reg-
ulators that inhibit and promote RsmYZ expression, respectively,
through GacAS (45–47). To test this idea, we constructed gacA,
gacS, retS, and ladS transcriptional reporters (PgacA-lacZ, PgacS-lacZ,
PretS-lacZ, and PladS-lacZ) and measured activity in wt PA103 and
mucA strains. Compared to in wt PA103, the PgacA-lacZ, PgacS-lacZ,
PretS-lacZ, and PladS-lacZ reporters were unchanged in the mucA mu-
tant (see Fig. S3A in the supplemental material). Additionally,
expression of pAlgR in wt PA103 did not alter reporter activity
compared to that in PA103 carrying a vector control, with the
exception of the PgacS-lacZ reporter, which increased 50% (see
Fig. S3B in the supplemental material). Together, these data sug-
gest that while RsmYZ expression is increased in the mucA mu-
tant, expression of the GacAS/LadS/RetS regulatory components
is unaffected.
RsmA targets display differential sensitivity to the level of
free RsmA. To determine whether other RsmA-dependent phe-
notypes are altered in the mucA mutant, we constructed transla-
tional fusions with genes tssA1 and PA4492. Both genes were
placed under the control of their native promoters. A previous
study found that RsmA inhibits expression of both genes at the
posttranscriptional level through a direct interaction with their
respective mRNAs (28). Consistent with the previous report, the
PtssA1=-=lacZ and PPA4492=-=lacZ reporter activities were significantly
elevated in the rsmA mutant relative to in wt PA103 (Fig. 6). In the
mucA mutant, however, both reporter activities were similar to
that in wt PA103. These data suggest that mucA mutation does not
result in a global shift in expression of the RsmA regulon.
One model to account for our data is that the level of free RsmA
is only modestly reduced in the mucA mutant and may be within a
range that alters ExsA expression while leaving other RsmA targets
(e.g., tssA1) unaffected. To test this model, we introduced an ara-
binose-inducible RsmZ expression vector into wt PA103 with the
expectation that an increase in RsmZ would reduce the availability
of free RsmA. The resulting strains were cultured under low-Ca2
conditions over a range of arabinose concentrations and assayed
for PexsD-lacZ and PtssA1=-=lacZ reporter activities. As expected,
PexsD-lacZ reporter activity decreased when cells were cultured with
increasing concentrations of arabinose (Fig. 7A). Conversely, the
activity of the RsmA-repressible PtssA1=-=lacZ reporter increased in
response to elevated arabinose. Importantly, pRsmZ expression
with several arabinose concentrations (Fig. 7A, 0.2 mM and 1 mM
arabinose) resulted in a significant decrease in PexsD-lacZ activity
without significantly altering PtssA1=-=lacZ reporter activity. Neither
PexsD-lacZ nor PtssA1=-=lacZ expression was altered significantly by the
vector control (Fig. 7B). Together, these data suggest that ExsA
expression is sensitive to smaller alterations in free RsmA levels
compared to TssA1.
DISCUSSION
Clinical isolates from acute and chronic P. aeruginosa infections
can be differentiated from one another by their patterns of viru-
FIG 6 The RsmA regulon is not globally disrupted in the mucA mutant. The
indicated strains carrying the PlacUV5-exsCEBA=-=lacZ (PA103  33 CPRG units),
PtssA1=-=lacZ (PA103  3 CPRG units), or PPA4492=-=lacZ (PA103  19 CPRG
units) translational reporter were cultured under T3SS-inducing conditions
(with EGTA) until the A600 reached 1.0 and were assayed for reporter activity.
FIG 7 T3SS gene expression is sensitive to smaller changes in RsmA availabil-
ity compared to TssA1. (A) PA103 transformed with an RsmZ expression
vector (pRsmZ) was cultured under T3SS-inducing conditions (with EGTA)
in the absence or presence of increasing concentrations of arabinose as indi-
cated and was assayed for reporter activity. The activity of the PexsD-lacZ re-
porter was 2,374 Miller units in the absence of arabinose, and the activity of the
PtssA1=-=lacZ reporter was 961 CPRG units in the presence of 25 mM arabinose.
***, P 	 0.0001. (B) PA103 transformed with a vector control (pJN105) was
cultured as described above and assayed for PexsD-lacZ and PtssA1=-=lacZ reporter
activity.
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lence gene expression. Those patterns are controlled, in part,
through global regulatory systems, including the AlgU-MucA al-
ternative sigma factor, cAMP-Vfr signaling, and RsmAYZ sys-
tems. Previous studies established that mucA, vfr, and rsmA mu-
tants each have a significant reduction in T3SS gene expression
(25–28). In this study, we demonstrate that cross talk between
these pathways coordinates T3SS gene expression. A key mediator
of this cross talk is the AlgZR two-component system. Our data
indicate that AlgR inhibits T3SS gene expression through two dis-
tinct mechanisms (Fig. 8). First, as reported previously, AlgR in-
hibits Vfr expression (26). Interestingly, a strain engineered to
constitutively express the exsCEBA operon (UY339) was no longer
dependent upon Vfr for maximal T3SS gene expression (Fig. 1A
versus 2C). This finding suggests that Vfr may regulate transcrip-
tion of the exsCEBA operon through the PexsC promoter. Regula-
tion by Vfr is likely indirect, however, as we have been unable to
demonstrate direct binding of Vfr to the PexsC promoter region
(data not shown). The second AlgR-dependent inhibitory mech-
anism involves recalibration of the RsmAYZ regulatory system to
inhibit ExsA expression at a posttranscriptional level. Although
previous studies reported that T3SS expression is RsmA depen-
dent, our finding that RsmA positively regulates ExsA expression
at the posttranscriptional level is novel. Whether the effect of
RsmA on exsA expression is direct or indirect and working at the
level of translation, the level of mRNA stability, or in some other
way will be the subject of future studies.
An alternative interpretation of our findings that we consid-
ered relates to the negative-feedback feature of the ExsCEDA reg-
ulatory cascade. Under noninducing conditions (high Ca2), the
ExsD antiactivator forms a complex with ExsA to inhibit T3SS
gene expression. We have proposed that modest changes in ExsA
expression (perhaps as small as 2-fold) are sufficient to overcome
ExsD-mediated inhibition (58). Increasing Vfr and RsmA activity
in the mucA mutant, both of which have positive effects on ExsA
expression, could nonspecifically suppress the true nature of the
mucA defect. Nevertheless, we do not believe this is occurring, as
neither Vfr nor RsmA alone (i.e., deletion of rsmYZ) is sufficient to
restore T3SS gene expression in the mucA mutant. We propose,
therefore, that it is the combined loss of Vfr and RsmA activity in
the mucA mutant that accounts for reduced exsA expression and
the corresponding lack of T3SS gene expression (Fig. 8). In sup-
port of that model, simultaneous restoration of both RsmA and
Vfr activity in the mucA mutant fully restored T3SS activity to wt
levels.
RsmAYZ expression is increased in mucA mutants through an
AlgR-dependent mechanism (Fig. 5A and B). We used epistasis
analyses to investigate the relationships between AlgR, the GacAS/
LadS/RetS regulatory system, and RsmA itself. We found that pre-
viously known regulatory networks (GacAS and RsmA) were nec-
essary for RsmYZ expression in the mucA mutant (Fig. 5C and D).
These data suggest that AlgR works together with known regula-
tory systems to modify RsmYZ expression levels but does control
them independently. For this reason, we do not believe that AlgR
directly interacts with the rsmY and rsmZ promoter regions to
control expression. AlgR also does not seem with work through
regulation of GacAS/LadS/RetS expression (see Fig. S3A and B in
the supplemental material). These data suggest that AlgR is a novel
regulator of RsmYZ expression, but the mechanism of action re-
mains undefined. Future studies will focus on whether AlgR di-
rectly activates PrsmA transcription or whether AlgR acts to in-
crease RsmA expression indirectly.
Although our data demonstrate that expression of the
PrsmA-lacZ, PrsmY-lacZ, and PrsmZ-lacZ transcriptional reporters in-
creased 2- to 3-fold in the mucA mutant (Fig. 5A), it is unclear how
this could result in a net reduction in the level of free RsmA.
Several lines of evidence indicate that RsmA homeostasis is tightly
controlled. Data from this study and others have shown that
rsmYZ transcription requires RsmA (Fig. 4B) (57). We also found
that plasmid-expressed RsmA results in a significant increase in
expression of the PrsmY-lacZ and PrsmZ-lacZ reporters. When RsmA
expression is induced, therefore, there is a compensatory increase
in RsmYZ that governs the level of free RsmA. In addition, a recent
study found that RsmA autoregulates its own translation through
a direct interaction with the rsmA mRNA (59). Increased RsmA
expression in the mucA mutant, therefore, could result in a net
decrease in free RsmA through inhibition of its own translation
and through elevated production of RsmYZ, both of which are
able to sequester 4 to 6 RsmA dimers (40, 41). Such a mechanism
is predicated on the assumption that the concentration of free
RsmA in wt cells is near the equilibrium binding constant for
RsmYZ. Another mechanism that could reduce the level of free
RsmA in the mucA mutant is increased expression of one or more
transcripts that are targets for RsmA-mediated regulation. In-
creased expression of those targets could have a sequestering effect
similar to that of RsmYZ, thereby resulting in a net decrease in free
RsmA. A recent study found that fimbrial gene expression in Sal-
monella enterica serovar Typhimurium is controlled through a
similar mechanism (60).
Several studies have shown that RsmA inhibits gene expression
FIG 8 Model for AlgR-dependent inhibition of T3SS gene expression in the
mucA mutant (see Discussion for details). Dashed lines depict the inner mem-
brane. Question marks indicate regulatory mechanisms that have been ob-
served but remain undefined by mechanism.
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through direct interactions with target mRNAs (28, 32). The pro-
totypical member of the family, CsrA, can also function as a direct
activator of gene expression (34). Although it is unclear whether
the exsA mRNA is a direct RsmA target, there are several potential
mechanisms that might account for our observation that the exsA
translational reporter responds to smaller changes in RsmA avail-
ability than tssA1. The simplest is that the binding affinity of RsmA
for the relevant T3SS target is lower than it is for tssA1. Under this
scenario, the intracellular pool of free RsmA would have to be near
the binding constant such that small fluctuations in free RsmA
alter expression of low-affinity RsmA targets. Conversely, larger
fluctuations in RsmA levels would be required to significantly alter
the expression of high-affinity targets. Another potential explana-
tion for the differential sensitivity of RsmA targets may be the
inherent properties of the gene being controlled. For instance, the
gene for a transcriptional regulator such as ExsA that participates
in a positive feedback loop to autoregulate its own expression
might be far more sensitive to changes in RsmA levels than a gene
encoding a structural protein lacking a regulatory function.
To the best of our knowledge, all studies conducted to date
have examined the output of the RsmA regulon at the extremes of
the potential spectrum, i.e., essentially all (gacAS, ladS, or rsmYZ
mutants) or nothing (retS or rsmA mutants). Whereas deletion of
rsmYZ or their activators (gacAS and ladS) results in high levels
of free RsmA, deletion of rsmA or retS results in complete loss of
RsmA. While such extremes have shed insight into the RsmA
regulon, it is more likely that RsmA availability fluctuates over a
much narrower range to fine-tune gene expression. Such an inter-
pretation is consistent with the fact that GacS, LadS, and RetS are
sensing proteins and presumably modulate gene expression in re-
sponse to environmental signals to control the output of the RsmA
regulon as a gradient as opposed to an on/off binary switch. Our
finding that RsmA availability in the mucA mutant is only modestly
reduced without resulting in a global shift in expression of the RsmA
regulon provides a physiologically relevant example of fluctuation
occurring toward the middle of the potential spectrum.
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